Surgical management of esophagogastric junction tumors.
Surgical resection with lymphadenectomy is the mainstay of treatment for all resectable esophagogastric junction tumors, prior to systemic generalization of the disease. This makes accurate pre-treatment staging and classification of the tumors most demanding. A well-established and internationally accepted classification for adenocarcinomas of the esophagogastric junction (AEG) helps to choose the appropriate surgical approach and to make results from different institutions comparable. Distal esophageal adenocarcinomas (AEG I) are distinguished from true cardia carcinomas (AEG II) and subcardiac gastric cancers (AEG III). Substantial advancements in this surgical field during the preceding decades have clearly revealed that individualization of the surgical strategy is the key to successfully approaching these entities. In this review we discuss the surgical management of esophagogastric junction tumors with a tailored surgical strategy.
von Rahden
Burkhard H A
BH
Department of Surgery, Technische Universitat Munchen, Ismaningerstr 22, Munchen D-81675, Germany. vrahden@nt1.chir.med.tu-muenchen.de
Stein
Hubert J
HJ
Siewert
J Rüdiger
JR
D000230:Adenocarcinoma / Q000453:epidemiology / Q000503:physiopathology / Q000601:surgery* / Q000628:therapy; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000453:epidemiology / Q000503:physiopathology / Q000601:surgery* / Q000628:therapy; D016629:Esophagectomy; D004943:Esophagogastric Junction / Q000503:physiopathology / Q000601:surgery*; D005743:Gastrectomy; D006801:Humans; D008197:Lymph Node Excision; D009367:Neoplasm Staging; D013156:Splenectomy; D013274:Stomach Neoplasms / Q000453:epidemiology / Q000503:physiopathology / Q000601:surgery* / Q000628:therapy